FindTrial
Sign In

Feasibility study of intratumoral gold marker placement and cone beam CT for image- guided radiotherapy in rectal cancer

Feasibility study of intratumoral gold marker placement and cone beam CT for image- guided radiotherapy in rectal cancer - Fiducial markers in rectal cancer

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38849
Enrollment
20
Registered
2013-10-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rectal cancer

Interventions

None listed

Sponsors

Medisch Universitair Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients with histological or cytological proven rectal cancer, treated with long course external beam radiotherapy (both conformal and IMRT radiation therapy techniques are allowed) - Age >

Exclusion criteria

Exclusion criteria: Patients using anticoagulants (platelet aggregation inhibitors and coumarines)

Design outcomes

Primary

MeasureTime frame
Primary endpoint is the concordance index between observers on kV CBCT—

Secondary

MeasureTime frame
Secondary endpoints: - % of marker loss - intra-observer variation in GTV localization with and without markers - tumor movement - use of goldmarkers for automatic online matching - development of SIB technique—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)